PHASE I/II STUDY OF LETAZURIL FOR AIDS-RELATED CRYTOSPORIDIAL DISEASE

Letazuril 治疗艾滋病相关隐孢子虫病的 I/II 期研究

• 批准号: 3785779
• 负责人: DOUGLAS DIETERICH
• 金额: --
• 依托单位: NEW YORK UNIVERSITY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3785779
• 关键词: AIDS therapy; antiprotozoal agents; clinical trials; cryptosporidiosis; drug screening /evaluation; gastrointestinal agents; human subject; human therapy evaluation; pharmacokinetics

This is a phase I/II trial to determine the pharmacokinetics profile of single doses of letrazuril in patients with AIDS-related cryptosporidial diarrhea. It will evaluate the safety and efficacy of escalating doses of letrazuril, compared with placebo, for patients with this disease.

这是一项I/II期试验，旨在确定 来曲珠利单次给药治疗艾滋病相关隐孢子虫病 腹泻它将评估逐步增加剂量的安全性和有效性 来曲珠利与安慰剂相比，对这种疾病的患者。